1Jemal, A, Siegel, R, Ward, E, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56, 106–130.
2Jemal, A, Siegel, R, Xu, J, et al. (2010) Cancer statistics, 2010. CA Cancer J Clin 60, 277–300.
3Instituto Nacional de Estadísticas, Geografía e Informática (2008), Mexico. Información sobre Tumores Malignos (National Institute of Statistics, Geography and Informatics, Mexico. Information on Malignant Tumors): INEGI. http://www.inegi.org.mx.
4Michels, KB (2005) The role of nutrition in cancer development and prevention. Int J Cancer 114, 163–165.
5Millen, AE, Subar, AF, Grawbard, BI, et al. (2007) Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial. Am J Clin Nutr 86, 1754–1764.
6Lanza, E, Hartman, TJ, Albert, PS, et al. (2006) High dry bean intake and reduced risk of advanced colorectal adenoma recurrence among participants in the Polyp Prevention Trial. J Nutr 136, 1896–1903.
7Vergara-Castañeda, HA, Guevara-Gonzalez, RG, Ramos-Gómez, M, et al. (2010) Non-digestible fraction of cooked bean (Phaseolus vulgaris L.) cultivar Bayo Madero suppresses colonic aberrant crypt foci in azoxymethane-induced rats. Food Funct 1, 294–300.
8Torruco-Uco, J, Chel-Guerrero, L, Martínez-Ayala, A, et al. (2009) Angiotensin-I converting enzyme inhibitory and antioxidant activities of protein hydrolysates from Phaseolus lunatus and Phaseolus vulgaris seeds. Food Sci Technol 42, 1597–1604.
9Campos-Vega, R, Reynoso-Camacho, R, Pedraza-Aboytes, G, et al. (2009) Chemical composition and in vitro polysaccharide fermentation of different beans (Phaseolus vulgaris L.). J Food Sci 74, 59–65.
10Chen, J, Ghazawi, FM, Bakkar, W, et al. (2006) Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B. Mol Cancer 5, 71.
11Veeriah, S, Hofmann, T, Glei, M, et al. (2007) Apple polyphenols and products formed in the gut differently inhibit survival of human cell lines derived from colon adenoma (LT97) and carcinoma (HT29). J Agric Food Chem 55, 2892–2900.
12Kuntz, S, Kunz, C & Rudloff, S (2009) Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells. Br J Nutr 101, 1306–1315.
13Feregrino-Pérez, AA, Berumen, LC, García-Alcocer, G, et al. (2008) Composition and chemopreventive effect of polysaccharides from common beans (Phaseolus vulgaris L.) on azoxymethane-induced colon cancer. J Agric Food Chem 56, 8737–8744.
14Campos-Vega, R, Guevara-Gonzalez, RG, Guevara-Olvera, BL, et al. (2010) Bean (Phaseolus vulgaris L.) polysaccharides modulate gene expression in human colon cancer cells (HT-29). Food Res Int 43, 1057–1064.
15Aparicio-Fernández, XO, Manzo-Bonilla, L & Loarca-Piña, GF (2005) Comparison of antimutagenic activity of phenolic compounds in newly harvested and stored common beans Phaseolus vulgaris against aflatoxin B1. J Food Sci 70, S73–S78.
16Kurtzman, RH & Halbrook, WU (1970) Polysaccharide from dry navy beans, Phaseolus vulgaris: its isolation and stimulation of clostridium perfringens. Appl Microbiol 20, 715–719.
17Del Razo, LM, Garcia-Vargas, GG, Garcia-Salcedo, J, et al. (2002) Arsenic levels in cooked food and assessment of adult dietary intake of arsenic in the Region Lagunera, Mexico. Food Chem Toxicol 40, 1423–1431.
18Ho, J & Benchimol, S (2003) Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10, 404–408.
19Rahman-Roblick, R, Roblick, UJ, Hellman, U, et al. (2007) p53 targets identified by protein expression profiling. PNAS 104, 5401–5406.
20Li, L, Rao, JN, Guo, X, et al. (2001) Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 281, 941–953.
21Mahyar-Roemer, M & Roemer, K (2001) p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents. Oncogene 20, 3387–3398.
22Damia, G & Broggini, M (2004) Cell cycle checkpoint proteins and cellular response to treatment by anticancer agents. Cell Cycle 3, 46–50.
23Maeda, T, Chong, MT, Espino, RA, et al. (2002) Role of p21Waf-1 in regulating the G1 and G2/M checkpoints in ultraviolet-irradiated keratinocytes. J Invest Dermatol 119, 513–521.
24Foijer, F & Te Riele, H (2006) Restriction beyond the restriction point: mitogen requirement for G2 passage. Cell Div 1, 1–5.
25Robertson, KD, Ait-Si-Ali, S, Yokochi, T, et al. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat Genet 25, 338–342.
26Robert, MF, Morin, S, Beaulieu, N, et al. (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33, 61–65.
27Harford, TJ, Shaltouki, A & Weyman, CM (2010) Increased expression of the pro-apoptotic Bcl2 family member PUMA and apoptosis by the muscle regulatory transcription factor MyoD in response to a variety of stimuli. Apoptosis 15, 71–82.
28Kawakami, K, Ruszkiewicz, A, Bennett, G, et al. (2006) DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer. Br J Cancer 94, 593–598.
29Hiranuma, C, Kawakami, K, Oyama, K, et al. (2004) Hypermethylation of the MYOD1 gene is a novel prognostic factor in patients with colorectal cancer. Int J Mol Med 13, 413–417.
30Imbriano, C, Gurtner, A, Cocchiarella, F, et al. (2005) Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters. Mol Cell Biol 25, 3737–3751.
31Hildesheim, J & Fornace, AJ (2002) Gadd45a: an elusive yet attractive candidate gene in pancreatic cancer. Clin Cancer Res 8, 2475–2479.
32Jung, HJ, Kim, EH, Mun, JY, et al. (2007) Base excision DNA repair defect in Gadd45a-deficient cells. Oncogene 26, 7517–7525.
33Li, M, Liu, L, Wang, Z, et al. (2008) Overexpression of hMSH2 and hMLH1 protein in certain gastric cancers and their surrounding mucosae. Oncol Rep 19, 401–406.
34Sengupta, S & Roychoudhury, S (2005) DNA double strand break and repair: mechanisms and involvement in human cancer. Int J Hum Genet 5, 1–10.
35Hermeking, H, Lengauer, C, Polyak, K, et al. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1, 3–11.
36Laronga, C, Yang, HY, Neal, C, et al. (2000) Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J Biol Chem 275, 23106–23112.
37Luk, SCW, Siu, SWF, Lai, CK, et al. (2005) Cell cycle arrest by a natural product via G2/M checkpoint. Int J Med Sci 2, 64–69.
38Lam, EWF, Francis, RE & Petkovic, M (2006) FOXO transcription factors: key regulators of cell fate. Biochem Soc Trans 34, 722–726.
39Greer, EL & Brunet, A (2005) FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410–7425.
40You, H, Yamamoto, K & Mak, TW (2006) Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. PNAS 103, 9051–9056.
41Frame, S & Balmain, A (2000) Integration of positive and negative growth signals during Ras pathway activation in vivo. Curr Opin Genet Dev 10, 06–113.
42O'Brate, A & Giannakakou, P (2003) The importance of p53 location: nuclear or cytoplasmic zip code? Bax-induced apoptotic cell death. Drug Resist Updat 6, 313–322.
43Pawlowski, J & Kraft, AS (2000) Bax-induced apoptotic cell death. PNAS 97, 529–531.
44Bai, J & Meng, Z (2005) Expression of apoptosis-related genes in livers from rats exposed to sulfur dioxide. Toxicology 216, 253–260.
45Ray, R, Chen, G, Velde, CV, et al. (2000) BNIP3 heterodimerizes with Bcl-2/Bcl-XL and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275, 1439–1448.
46Chen, L, Willis, SN, Wei, A, et al. (2005) Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17, 393–403.
47Marsden, VS, Ekert, PG, Van Delft, M, et al. (2004) Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 165, 775–780.
48Shrivastava, A, Tiwari, M, Sinha, RA, et al. (2006) Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving the mitochondria-mediated pathway. J Biol Chem 281, 19762–19771.
49Ravagnan, L, Roumier, T & Kroemer, G (2002) Mitochondria, the killer organelles and their weapons. J Cell Physiol 192, 131–137.
50Yu, Z, Li, W & Liu, F (2004) Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett 215, 159–166.
51Agrawal, S, Agarwal, ML, Chatterjee-Kishore, M, et al. (2002) Stat1-dependent, p53-independent expression of p21waf1 modulates oxysterol-induced apoptosis. Mol Cell Biol 22, 1981–1992.
52Lin, YL, Sengupta, S, Gurdziel, K, et al. (2009) p63 and p73 transcriptionally regulate genes involved in DNA repair. PLoS Genet 5, 1–13.
53Flores, ER, Tsai, KY, Crowley, D, et al. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 416, 560–564.
54Haier, J & Nicolson, GL (2002) PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 21, 1450–1460.
55Campbell, KJ, Rocha, S & Perkins, ND (2004) Active repression of antiapoptotic gene expression by RelA (p65) NF-κB. Mol Cell 13, 853–865.
56Fujioka, S, Schmidt, C, Sclabas, GM, et al. (2004) Stabilization of p53 is a novel mechanism for proapoptotic function of NF-κB. J Biol Chem 279, 27549–27559.
57Wu, ZH & Miyamoto, S (2008) Induction of a pro-apoptotic ATM-NF-κB pathway and its repression by ATR in response to replication stress. EMBO J 27, 1963–1973.
58Maeda, S & Karin, M (2003) Oncogene at last c-Jun promotes liver cancer in mice. Cancer Cell 3, 102–104.
59Cahill, CM & Rogers, JT (2008) Interleukin (IL) 1β induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/Iβ kinase α pathway targeting activator protein-1. J Biol Chem 283, 25900–25912.
60Ahn, KS & Aggarwal, BB (2005) Transcription factor NF-κB. A sensor for smoke and stress signals. Ann NY Acad Sci 1056, 218–233.
61Clemo, NK, Collard, TJ, Southern, SL, et al. (2008) BAG-1 is up-regulated in colorectal tumour progression and promotes colorectal tumour cell survival through increased NF-κB activity. Carcinogenesis 29, 849–857.
62Chen, WC, Liu, Q, Fu, XJ, et al. (2004) Expression of survivin and its significance in colorectal cancer. World J Gastroenterol 10, 2886–2889.
63Ohki, R, Nemoto, J, Murasawa, H, et al. (2004) Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem 275, 22627–22630.
64Nair, VD, Yuen, T, Olanow, CW, et al. (2004) Early single cell bifurcation of pro- and antiapoptotic states during oxidative stress. J Biol Chem 279, 27494–27501.
65Iacomino, G, Tecce, MF, Grimaldi, C, et al. (2001) Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate. Biochem Biophys Res Commun 285, 1280–1289.
66Kosinski, C, Li, VSW, Chan, ASY, et al. (2007) Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. PNAS 104, 15418–15423.